Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	58.04	97.47	79.51	164.89	87.43	11.97
Short-Term Investments	155.03	326.68	446.73	285.61	211.94	16.3
Cash & Short-Term Investments	213.07	424.15	526.24	450.5	299.37	28.27
Cash Growth	-54.45%	-19.40%	16.81%	50.48%	958.99%	-8.91%
Accounts Receivable	57.32	51.13	52.75	139.15	185.24	6.71
Other Receivables	7.58	6.31	22.36	4.15	18.83	0.49
Receivables	64.9	57.45	75.11	143.3	204.06	7.2
Prepaid Expenses	7.07	7.74	6.81	4.24	3.68	1.29
Other Current Assets	41.51	18.5	19.71	13.92	16.51	0.32
Total Current Assets	326.54	507.85	627.87	611.96	523.62	37.08
Property, Plant & Equipment	113.69	95.62	98.92	71.16	41.03	8.61
Long-Term Investments	627.16	444.01	339.03	507.01	132.5	42.82
Goodwill	22.06	22.06	143.03	50.9	-	-
Other Intangible Assets	137.12	143.05	150.64	35.91	-	-
Long-Term Deferred Tax Assets	-	-7.96	3.5	0.76	1.63	-
Other Long-Term Assets	7.21	30.71	23.05	1.02	1.69	0.25
Total Assets	1,234	1,235	1,386	1,279	700.46	88.76
Accounts Payable	19.81	15.36	23.09	20.49	26.39	1.58
Accrued Expenses	21.93	26.24	17.91	15.52	8.54	1.33
Short-Term Debt	-	-	15	21.28	15.02	-
Current Portion of Long-Term Debt	0.41	1.18	5.64	-	-	-
Current Portion of Leases	1.93	4.5	7.08	2.17	-	0.42
Current Income Taxes Payable	-	-	-	0.79	53.32	0.02
Current Unearned Revenue	2.97	2.87	3.2	14.57	26.58	0.37
Other Current Liabilities	26.95	22.86	16.2	30.49	0.27	-
Total Current Liabilities	73.99	73.02	88.11	105.31	130.12	3.72
Long-Term Leases	5.11	7.91	10.61	6.74	0.57	2.26
Long-Term Deferred Tax Liabilities	6.73	7.96	-	-	-	-
Other Long-Term Liabilities	10.54	13.16	17.46	0.79	0.39	-
Total Liabilities	98.87	102.04	116.18	112.84	131.07	5.98
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	532.91	501.72	486.59	501.91	418.07	146.06
Retained Earnings	596.36	633.18	801	657.6	150.88	-63.43
Comprehensive Income & Other	9.18	1.21	-20.9	-0.76	0.44	0.15
Total Common Equity	1,138	1,136	1,267	1,159	569.39	82.78
Minority Interest	-3.55	-2.82	3.19	7.13	-	-
Shareholders' Equity	1,135	1,133	1,270	1,166	569.39	82.78
Total Liabilities & Equity	1,234	1,235	1,386	1,279	700.46	88.76
Total Debt	9.95	13.59	38.33	30.2	15.59	2.68
Net Cash (Debt)	805.36	834.13	814.56	905.35	416.28	67.54
Net Cash Growth	-3.14%	2.40%	-10.03%	117.48%	516.35%	80.49%
Net Cash Per Share	26.83	28.01	26.31	29.23	17.30	3.61
Filing Date Shares Outstanding	30.59	29.78	29.52	30.25	28.87	21.56
Total Common Shares Outstanding	30.54	29.65	29.44	30.16	28.18	21.48
Working Capital	252.55	434.83	539.77	506.65	393.5	33.36
Book Value Per Share	37.28	38.31	43.03	38.42	20.21	3.85
Tangible Book Value	979.28	970.99	973.02	1,072	569.39	82.78
Tangible Book Value Per Share	32.07	32.75	33.05	35.54	20.21	3.85
Land	17.35	8.8	7.5	7.5	7.5	-
Buildings	48.21	17.53	12.6	10.67	7.44	-
Machinery	74.95	73.65	71.97	51.22	31.6	12.43
Leasehold Improvements	3.35	11.22	11.8	4	1.58	0.88

Source: S&P Capital IQ. Standard template. Financial Sources.